Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Medtronic
AstraZeneca
Johnson and Johnson
Merck

Last Updated: August 8, 2022

Investigational Drug Information for Beloranib


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Beloranib?

Beloranib is an investigational drug.

There have been 8 clinical trials for Beloranib. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2014.

The most common disease conditions in clinical trials are Obesity, Prader-Willi Syndrome, and Overweight. The leading clinical trial sponsors are Zafgen, Inc. and [disabled in preview].

There are sixty-seven US patents protecting this investigational drug and seven hundred and eighty-eight international patents.

Recent Clinical Trials for Beloranib
TitleSponsorPhase
An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes MellitusZafgen, Inc.Phase 2
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi SyndromeZafgen, Inc.Phase 3
An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic InjuryZafgen, Inc.Phase 2

See all Beloranib clinical trials

Clinical Trial Summary for Beloranib

Top disease conditions for Beloranib
Top clinical trial sponsors for Beloranib

See all Beloranib clinical trials

US Patents for Beloranib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Beloranib See Plans and Pricing METAP2 inhibitors and methods of treating obesity SynDevRx, Inc. (Cambridge, MA) See Plans and Pricing
Beloranib See Plans and Pricing Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome Essentialis, Inc. (Redwood City, CA) See Plans and Pricing
Beloranib See Plans and Pricing Anti-Laminin4 antibodies specific for LG4-5 PROTHENA BIOSCIENCES LIMITED (Dublin, IE) See Plans and Pricing
Beloranib See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
Beloranib See Plans and Pricing Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk ELCELYX THERAPEUTICS, INC. (San Diego, CA) See Plans and Pricing
Beloranib See Plans and Pricing ACC inhibitors and uses thereof Gilead Apollo, LLC (Foster City, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Beloranib

Drugname Country Document Number Estimated Expiration Related US Patent
Beloranib Argentina AR095828 2033-04-10 See Plans and Pricing
Beloranib Australia AU2014250983 2033-04-10 See Plans and Pricing
Beloranib Brazil BR112015025892 2033-04-10 See Plans and Pricing
Beloranib Canada CA2908993 2033-04-10 See Plans and Pricing
Beloranib China CN105431426 2033-04-10 See Plans and Pricing
Beloranib China CN112494476 2033-04-10 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Medtronic
AstraZeneca
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.